SOPHiA GENETICS SA (SOPH) Stock Forecast, Price Target & Predictions
SOPH Stock Forecast
SOPHiA GENETICS SA stock forecast is as follows: an average price target of $5.67 (represents a 71.82% upside from SOPH’s last price of $3.30) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
SOPH Price Target
The average price target for SOPHiA GENETICS SA (SOPH) is $5.67 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $5.00. This represents a potential 71.82% upside from SOPH's last price of $3.30.
SOPH Analyst Ratings
According to 4 Wall Street analysts, SOPHiA GENETICS SA's rating consensus is 'Buy'. The analyst rating breakdown for SOPH stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
SOPHiA GENETICS SA Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 07, 2024 | Tejas Savant | Morgan Stanley | $5.00 | $3.92 | 27.55% | 51.52% |
| Jun 27, 2024 | Subbu Nambi | Guggenheim | $6.00 | $4.51 | 32.89% | 81.82% |
| Jan 03, 2023 | Mark Massaro | BTIG | $6.00 | $2.06 | 191.26% | 81.82% |
The latest SOPHiA GENETICS SA stock forecast, released on Aug 07, 2024 by Tejas Savant from Morgan Stanley, set a price target of $5.00, which represents a 27.55% increase from the stock price at the time of the forecast ($3.92), and a 51.52% increase from SOPH last price ($3.30).
SOPHiA GENETICS SA Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $5.50 |
| Last Closing Price | $3.30 | $3.30 | $3.30 |
| Upside/Downside | -100.00% | -100.00% | 66.67% |
In the current month, the average price target of SOPHiA GENETICS SA stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to SOPHiA GENETICS SA's last price of $3.30. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 11, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Aug 07, 2024 | Morgan Stanley | - | Equal-Weight | Downgrade |
| Aug 07, 2024 | Morgan Stanley | - | Positive | Downgrade |
| Jun 27, 2024 | Guggenheim | - | Buy | Initialise |
| May 28, 2024 | BTIG | Buy | Buy | Hold |
SOPHiA GENETICS SA's last stock rating was published by Cowen & Co. on Sep 11, 2024. The company gave SOPH a "Buy" rating, the same as its previous rate.
SOPHiA GENETICS SA Financial Forecast
SOPHiA GENETICS SA Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $13.97M | $13.38M | $11.65M | $11.67M | $10.86M | $10.94M | $10.36M | $10.18M |
| Avg Forecast | $26.63M | $22.53M | $22.99M | $19.85M | $21.51M | $19.26M | $18.36M | $17.26M | $18.09M | $15.86M | $17.40M | $16.45M | $17.33M | $15.45M | $15.24M | $13.89M | $12.92M | $11.45M | $11.95M | $10.69M | $11.20M | $9.90M | $8.72M |
| High Forecast | $27.23M | $23.04M | $23.51M | $20.30M | $22.00M | $19.69M | $18.77M | $17.94M | $18.50M | $16.05M | $17.40M | $16.45M | $17.35M | $15.54M | $15.59M | $14.20M | $13.21M | $11.45M | $11.95M | $10.69M | $11.20M | $9.90M | $8.72M |
| Low Forecast | $25.97M | $21.97M | $22.42M | $19.36M | $20.98M | $18.78M | $17.90M | $16.61M | $17.64M | $15.67M | $17.40M | $16.45M | $17.29M | $15.36M | $14.86M | $13.54M | $12.60M | $11.45M | $11.95M | $10.69M | $11.20M | $9.90M | $8.72M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.04% | 1.02% | 0.98% | 1.02% | 0.98% | 1.05% | 1.17% |
SOPHiA GENETICS SA's average Quarter revenue forecast for Jun 23 based on 1 analysts is $15.24M, with a low forecast of $14.86M, and a high forecast of $15.59M. SOPH's average Quarter revenue forecast represents a 9.12% increase compared to the company's last Quarter revenue of $13.97M (Mar 23).
SOPHiA GENETICS SA EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-17.40M | $-15.08M | $-22.19M | $-22.69M | $-23.83M | $-21.14M | $-19.50M | $-15.22M |
| Avg Forecast | $-26.63M | $-22.53M | $-22.99M | $-19.85M | $-21.51M | $-19.26M | $-18.36M | $-17.26M | $-18.09M | $-15.86M | $-17.40M | $-16.45M | $-17.33M | $-15.45M | $-15.24M | $-13.89M | $-12.92M | $-11.45M | $-11.95M | $-10.69M | $-11.20M | $-9.90M | $-8.72M |
| High Forecast | $-25.97M | $-21.97M | $-22.42M | $-19.36M | $-20.98M | $-18.78M | $-17.90M | $-16.61M | $-17.64M | $-15.67M | $-17.40M | $-16.45M | $-17.29M | $-15.36M | $-14.86M | $-13.54M | $-12.60M | $-11.45M | $-11.95M | $-10.69M | $-11.20M | $-9.90M | $-8.72M |
| Low Forecast | $-27.23M | $-23.04M | $-23.51M | $-20.30M | $-22.00M | $-19.69M | $-18.77M | $-17.94M | $-18.50M | $-16.05M | $-17.40M | $-16.45M | $-17.35M | $-15.54M | $-15.59M | $-14.20M | $-13.21M | $-11.45M | $-11.95M | $-10.69M | $-11.20M | $-9.90M | $-8.72M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.25% | 1.17% | 1.94% | 1.90% | 2.23% | 1.89% | 1.97% | 1.75% |
undefined analysts predict SOPH's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than SOPHiA GENETICS SA's previous annual EBITDA (undefined) of $NaN.
SOPHiA GENETICS SA Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-19.70M | $-13.97M | $-23.31M | $-24.68M | $-25.49M | $-21.37M | $-21.24M | $-18.39M |
| Avg Forecast | $-2.66M | $-7.30M | $-7.97M | $-12.61M | $-11.55M | $-11.95M | $-12.61M | $-15.14M | $-14.47M | $-14.74M | $-17.66M | $-16.26M | $-14.44M | $-19.91M | $-19.51M | $-20.22M | $-22.70M | $-23.95M | $-25.93M | $-21.73M | $-23.51M | $-23.51M | $-25.49M |
| High Forecast | $-2.57M | $-7.07M | $-7.71M | $-12.21M | $-11.18M | $-11.56M | $-12.21M | $-14.65M | $-14.00M | $-14.26M | $-17.09M | $-15.74M | $-13.97M | $-19.27M | $-18.88M | $-19.56M | $-21.96M | $-23.95M | $-25.93M | $-21.73M | $-23.51M | $-23.51M | $-25.49M |
| Low Forecast | $-2.73M | $-7.52M | $-8.20M | $-12.98M | $-11.89M | $-12.30M | $-12.98M | $-15.58M | $-14.90M | $-15.17M | $-18.18M | $-16.74M | $-14.86M | $-20.50M | $-20.09M | $-20.81M | $-23.36M | $-23.95M | $-25.93M | $-21.73M | $-23.51M | $-23.51M | $-25.49M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 0.62% | 0.97% | 0.95% | 1.17% | 0.91% | 0.90% | 0.72% |
SOPHiA GENETICS SA's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SOPH's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
SOPHiA GENETICS SA SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $19.67M | $18.18M | $20.73M | $22.93M | $22.24M | $21.53M | $19.39M | $15.80M |
| Avg Forecast | $39.83M | $33.70M | $34.39M | $29.70M | $32.18M | $28.81M | $27.46M | $25.82M | $27.07M | $23.73M | $26.03M | $24.61M | $25.92M | $23.11M | $22.80M | $20.78M | $19.32M | $16.99M | $17.73M | $15.86M | $16.62M | $14.69M | $12.93M |
| High Forecast | $40.73M | $34.47M | $35.16M | $30.37M | $32.91M | $29.46M | $28.09M | $26.84M | $27.68M | $24.01M | $26.03M | $24.61M | $25.95M | $23.25M | $23.31M | $21.25M | $19.76M | $16.99M | $17.73M | $15.86M | $16.62M | $14.69M | $12.93M |
| Low Forecast | $38.84M | $32.87M | $33.53M | $28.96M | $31.38M | $28.09M | $26.78M | $24.84M | $26.39M | $23.44M | $26.02M | $24.61M | $25.87M | $22.97M | $22.23M | $20.26M | $18.84M | $16.99M | $17.73M | $15.86M | $16.62M | $14.69M | $12.93M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 0.94% | 1.22% | 1.29% | 1.40% | 1.30% | 1.32% | 1.22% |
SOPHiA GENETICS SA's average Quarter SG&A projection for Jun 23 is $22.80M, based on 1 Wall Street analysts, with a range of $22.23M to $23.31M. The forecast indicates a 15.93% rise compared to SOPH last annual SG&A of $19.67M (Mar 23).
SOPHiA GENETICS SA EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.31 | $-0.22 | $-0.36 | $-0.39 | $-0.40 | $-0.39 | $-0.35 | $-0.29 |
| Avg Forecast | $-0.04 | $-0.11 | $-0.12 | $-0.19 | $-0.17 | $-0.18 | $-0.19 | $-0.23 | $-0.22 | $-0.22 | $-0.27 | $-0.24 | $-0.22 | $-0.30 | $-0.29 | $-0.30 | $-0.34 | $-0.36 | $-0.39 | $-0.33 | $-0.36 | $-0.36 | $-0.39 |
| High Forecast | $-0.04 | $-0.11 | $-0.12 | $-0.18 | $-0.17 | $-0.17 | $-0.18 | $-0.22 | $-0.21 | $-0.21 | $-0.26 | $-0.24 | $-0.21 | $-0.29 | $-0.28 | $-0.29 | $-0.33 | $-0.36 | $-0.39 | $-0.33 | $-0.36 | $-0.36 | $-0.39 |
| Low Forecast | $-0.04 | $-0.11 | $-0.12 | $-0.20 | $-0.18 | $-0.19 | $-0.20 | $-0.23 | $-0.22 | $-0.23 | $-0.27 | $-0.25 | $-0.22 | $-0.31 | $-0.30 | $-0.31 | $-0.35 | $-0.36 | $-0.39 | $-0.33 | $-0.36 | $-0.36 | $-0.39 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.64% | 0.99% | 0.99% | 1.21% | 1.09% | 0.98% | 0.75% |
According to undefined Wall Street analysts, SOPHiA GENETICS SA's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SOPH previous annual EPS of $NaN (undefined).
SOPHiA GENETICS SA Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| EVH | Evolent Health | $12.35 | $40.86 | 230.85% | Buy |
| CMAX | CareMax | $0.87 | $2.60 | 198.85% | Hold |
| DH | Definitive Healthcare | $4.12 | $9.50 | 130.58% | Hold |
| FORA | Forian | $2.03 | $4.50 | 121.67% | Buy |
| SLP | Simulations Plus | $28.29 | $56.00 | 97.95% | Buy |
| SOPH | SOPHiA GENETICS SA | $3.30 | $5.67 | 71.82% | Buy |
| PRVA | Privia Health Group | $20.95 | $33.82 | 61.43% | Buy |
| PINC | Premier | $22.39 | $33.25 | 48.50% | Hold |
| AUGX | Augmedix | $2.35 | $2.67 | 13.62% | Hold |
| HSTM | HealthStream | $31.31 | $29.00 | -7.38% | Buy |